ENALAPRIL GENERIC HEALTH enalapril maleate 20mg tablet blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

enalapril generic health enalapril maleate 20mg tablet blister pack

generic health pty ltd - enalapril maleate, quantity: 20 mg - tablet, uncoated - excipient ingredients: hypromellose; lactose monohydrate; iron oxide red; maleic acid; zinc stearate; iron oxide yellow; maize starch - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

ENALAPRIL GENERIC HEALTH enalapril maleate 10mg tablet blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

enalapril generic health enalapril maleate 10mg tablet blister pack

generic health pty ltd - enalapril maleate, quantity: 10 mg - tablet, uncoated - excipient ingredients: hypromellose; maleic acid; iron oxide red; zinc stearate; maize starch; lactose monohydrate - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

ENALAPRIL GENERIC HEALTH enalapril maleate 5mg tablet blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

enalapril generic health enalapril maleate 5mg tablet blister pack

generic health pty ltd - enalapril maleate, quantity: 5 mg - tablet, uncoated - excipient ingredients: maleic acid; zinc stearate; maize starch; hypromellose; lactose monohydrate - hypertension. enalapril generic health is indicated in the treatment of: all grades of essential hypertension; renovascular hypertension. congestive heart failure. enalapril generic health is indicated in the treatment of all degrees of symptomatic heart failure. in such patients it is recommended that enalapril be administered together with a diuretic. left ventricular dysfunction. all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35%, irrespective of the presence or severity of obvious symptoms of heart failure.

DOLAPRIL 4 trandolapril 4 mg capsule blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

dolapril 4 trandolapril 4 mg capsule blister pack

arrotex pharmaceuticals pty ltd - trandolapril, quantity: 4 mg - capsule - excipient ingredients: croscarmellose sodium; sodium stearylfumarate; titanium dioxide; gelatin; maize starch; povidone; lactose monohydrate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - treatment of hypertension. data to support the usage of trandolapril in renovascular hypertension are, at present, not available. trandolapril is also indicated for patients with left ventricular dysfuntion post myocardial infarction (ejection fraction less than or equal to 35% or wmi (wall motion index) less than or equal to 1.2).

DOLAPRIL 2 trandolapril 2 mg capsule blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

dolapril 2 trandolapril 2 mg capsule blister pack

arrotex pharmaceuticals pty ltd - trandolapril, quantity: 2 mg - capsule - excipient ingredients: brilliant blue fcf; maize starch; sodium stearylfumarate; erythrosine; lactose monohydrate; allura red ac; titanium dioxide; povidone; gelatin; croscarmellose sodium; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - treatment of hypertension. data to support the usage of trandolapril in renovascular hypertension are, at present, not available. trandolapril is also indicated for patients with left ventricular dysfuntion post myocardial infarction (ejection fraction less than or equal to 35% or wmi (wall motion index) less than or equal to 1.2).

DOLAPRIL 1 trandolapril 1 mg capsule blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

dolapril 1 trandolapril 1 mg capsule blister pack

arrotex pharmaceuticals pty ltd - trandolapril, quantity: 1 mg - capsule - excipient ingredients: titanium dioxide; croscarmellose sodium; gelatin; erythrosine; povidone; sunset yellow fcf; lactose monohydrate; sodium stearylfumarate; maize starch; brilliant blue fcf; allura red ac; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - treatment of hypertension. data to support the usage of trandolapril in renovascular hypertension are, at present, not available. trandolapril is also indicated for patients with left ventricular dysfuntion post myocardial infarction (ejection fraction less than or equal to 35% or wmi (wall motion index) less than or equal to 1.2).

DOLAPRIL 0.5 trandolapril 0.5 mg capsule blister pack Awstralja - Ingliż - Department of Health (Therapeutic Goods Administration)

dolapril 0.5 trandolapril 0.5 mg capsule blister pack

arrotex pharmaceuticals pty ltd - trandolapril, quantity: 0.5 mg - capsule - excipient ingredients: povidone; titanium dioxide; maize starch; croscarmellose sodium; sodium stearylfumarate; gelatin; lactose monohydrate; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; purified water; shellac; strong ammonia solution; iron oxide black; potassium hydroxide - treatment of hypertension. data to support the usage of trandolapril in renovascular hypertension are, at present, not available. trandolapril is also indicated for patients with left ventricular dysfuntion post myocardial infarction (ejection fraction less than or equal to 35% or wmi (wall motion index) less than or equal to 1.2).

TRANDOLAPRIL tablet Stati Uniti - Ingliż - NLM (National Library of Medicine)

trandolapril tablet

carilion materials management - trandolapril (unii: 1t0n3g9crc) (trandolaprilat - unii:rr6866vl0o) - trandolapril 1 mg - trandolapril tablets are indicated for the treatment of hypertension. it may be used alone or in combination with other antihypertensive medication such as hydrochlorothiazide. trandolapril tablets usp are indicated in stable patients who have evidence of left-ventricular systolic dysfunction (identified by wall motion abnormalities) or who are symptomatic from congestive heart failure within the first few days after sustaining acute myocardial infarction. administration of trandolapril to caucasian patients has been shown to decrease the risk of death (principally cardiovascular death) and to decrease the risk of heart failure-related hospitalization (see clinical pharmacology -heart failure or left-ventricular dysfunction post myocardial infarction for details of the survival trial). trandolapril tablets are contraindicated in patients who are hypersensitive to this product, in patients with hereditary/idiopathic angioedema and in patients with a history of angioedema related to previous treatment with an a